Biotech Sector Remains Undervalued - Oppenheimer
Go back to Biotech Sector Remains Undervalued - Oppenheimer| iShares Nasdaq Biotechnology Index Fund (NASDAQ: IBB) | Delayed: 202.40 +0.40 (0.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $202.00 | 52 Week High | $343.87 | |||
| Open | $202.49 | 52 Week Low | $240.03 | |||
| Day High | $204.16 | P/E | N/A | |||
| Day Low | $200.98 | EPS | $0.00 | |||
| Volume | 1,098,699 | |||||
| SPDR S&P BIOTECH ETF (NYSE: XBI) | Delayed: 154.18 +0.15 (0.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $154.03 | 52 Week High | $73.80 | |||
| Open | $154.37 | 52 Week Low | $44.16 | |||
| Day High | $156.04 | P/E | N/A | |||
| Day Low | $152.50 | EPS | $0.00 | |||
| Volume | 8,853,277 | |||||
